Evidence map›Paper›PMID 26309124›Full record

Observational studyPloS one2015

Seizure Outcomes and Predictors of Recurrent Post-Stroke Seizure: A Retrospective Observational Cohort Study.

Tomotaka Tanaka, Hiroshi Yamagami, Masafumi Ihara, Rie Motoyama, Kazuki Fukuma, Tetsuya Miyagi, Kazutaka Nishimura, Kazunori Toyoda, Kazuyuki Nagatsuka

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 51 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Observational
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Visualizing prolonged hyperperfusion in post-stroke epilepsy using postictal subtraction SPECT.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2021
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Poststroke epilepsy: current perspectives on diagnosis and treatment.Neuropsychiatric disease and treatment · 2019
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Tomotaka TanakaDepartment of Stroke and Cerebrovascular Diseases, Division of Neurology, Research Institute, National Cerebral and Cardiovascular Center, Osaka, Japan.
Hiroshi YamagamiDepartment of Stroke and Cerebrovascular Diseases, Division of Neurology, Research Institute, National Cerebral and Cardiovascular Center, Osaka, Japan.
Masafumi IharaDepartment of Stroke and Cerebrovascular Diseases, Division of Neurology, Research Institute, National Cerebral and Cardiovascular Center, Osaka, Japan.
Rie MotoyamaDepartment of Stroke and Cerebrovascular Diseases, Division of Neurology, Research Institute, National Cerebral and Cardiovascular Center, Osaka, Japan.
Kazuki FukumaDepartment of Stroke and Cerebrovascular Diseases, Division of Neurology, Research Institute, National Cerebral and Cardiovascular Center, Osaka, Japan.
Tetsuya MiyagiDepartment of Stroke and Cerebrovascular Diseases, Division of Cerebrovascular Medicine, Research Institute, National Cerebral and Cardiovascular Center, Osaka, Japan.
Kazutaka NishimuraDepartment of Stroke and Cerebrovascular Diseases, Division of Cerebrovascular Medicine, Research Institute, National Cerebral and Cardiovascular Center, Osaka, Japan.
Kazunori ToyodaDepartment of Stroke and Cerebrovascular Diseases, Division of Cerebrovascular Medicine, Research Institute, National Cerebral and Cardiovascular Center, Osaka, Japan.
Kazuyuki NagatsukaDepartment of Stroke and Cerebrovascular Diseases, Division of Neurology, Research Institute, National Cerebral and Cardiovascular Center, Osaka, Japan.
National Cerebral and Cardiovascular Center · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSeizure is a common complication after stroke (termed "post-stroke seizure," PSS). Although many studies have assessed outcomes and risk factors of PSS, no reliable predictors are currently available to determine PSS recurrence. We compared baseline clinical characteristics and post-stroke treatment regimens between recurrent and non-recurrent PSS patients to identify factors predictive of recurrence.

methodsConsecutive PSS patients admitted to our stroke center between January 2011 and July 2013 were monitored until February 2014 (median 357 days; IQR, 160-552) and retrospectively evaluated for baseline clinical characteristics and PSS recurrence. Cumulative recurrence rates at 90, 180, and 360 days post-stroke were estimated by Kaplan-Meier analysis. Independent predictors of recurrent PSS were identified by Cox proportional-hazards analysis.

resultsA total of 104 patients (71 men; mean age, 72.1 ± 11.2 years) were analyzed. PSS recurred in 31 patients (30%) during the follow-up. Factors significantly associated with PSS recurrence by log-rank analysis included previous PSS, valproic acid (VPA) monotherapy, polytherapy with antiepileptic drugs (AEDs), frontal cortical lesion, and higher modified Rankin Scale score at discharge (all p < 0.05). Independent predictors of recurrent PSS were age <74 years (HR 2.38, 95% CI 1.02-5.90), VPA monotherapy (HR 3.86, 95% CI 1.30-12.62), and convulsions on admission (HR 3.87, 95% CI 1.35-12.76).

conclusionsApproximately one-third of PSS patients experienced seizure recurrence within one year. The predictors of recurrent PSS were younger age, presence of convulsions and VPA monotherapy. Our findings should be interpreted cautiously in countries where monotherapy with second-generation AEDs has been approved because this study was conducted while second-generation AEDs had not been officially approved for monotherapy in Japan.

Indexed as

AgedAged, 80 and overFemaleFollow-Up StudiesHumansJapanMaleMiddle AgedPrevalencePrognosisRecurrenceRetrospective StudiesRisk FactorsSeizuresStroke

Identifiers

PMID26309124
PMCPMC4550357
OpenAlexW1921203906

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.